- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 4.1 Exhibit 4.1A
- 5.1 Exhibit 5.1
- 5.2 Exhibit 5.2
- 5.3 Exhibit 5.3
- 5.4 Exhibit 5.4
- 5.5 Exhibit 5.5
- 5.6 Exhibit 5.6
- 5.7 Exhibit 5.7
- 5.8 Exhibit 5.8
- 5.9 Exhibit 5.9
- 5.10 Exhibit 5.10
- 5.11 Exhibit 5.11
- 5.12 Exhibit 5.12
- 8.1 Exhibit 8.1
- 12.1 Exhibit 12.1
- 21 Exhibit 21
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 25 Exhibit 25
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 12 Nov 15 Registration of securities issued in business combination transactions
- 6 Oct 15 Registration of securities issued in business combination transactions
- 15 Jun 15 Registration of securities issued in business combination transactions (amended)
- 16 Apr 15 Registration of securities issued in business combination transactions
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-4 No. 333 - ) and related Prospectus of Omega Healthcare Investors, Inc. for the exchange of $600,000,000 of 5.250% Senior Notes due 2026 offered under a private placement for $600,000,000 of 5.250% Senior Notes due 2026 which have been registered under the Securities Act of 1933, as amended, and to the incorporation by reference therein of our reports dated February 27, 2015, with respect to the consolidated financial statements and schedules of Omega Healthcare Investors, Inc., and the effectiveness of internal control over financial reporting of Omega Healthcare Investors, Inc., included in its Annual Report (Form 10-K), as amended, for the year ended December 31, 2014, filed with the Securities and Exchange Commission.
| /s/ Ernst & Young LLP | |
| Baltimore, Maryland | |
| November 10, 2015 |